К содержанию
Dr. Tara EinullaevaMedical oncologist

Blood tests 10 min

Raised PSA: when it’s a reason to act and when it isn’t

Why PSA rises for reasons other than cancer, how to prepare for the test, what free PSA, PSA density and MRI add, and how PSA is followed after treatment.

Written and medically reviewed by

Dr. Tara Einullaeva

Medical oncologist, 9 years in practice. Credentials · reviewed 16 October 2026

A raised PSA is a reason to look more closely, not a diagnosis. PSA goes up with cancer, but also with benign prostate enlargement, inflammation, after ejaculation or a bike ride. Today the decision about a biopsy is not made on a single number, but on a repeat test, an MRI and a few additional measures.

What PSA is and why it rises for reasons other than cancer

PSA (prostate-specific antigen) is a protein made by the cells of the prostate gland — both healthy and cancerous ones. So the test tells you that “something is going on” in the prostate, but not what.

Besides cancer, PSA can be raised by:

  • Benign prostatic hyperplasia (age-related enlargement of the gland) — the most common cause in older men.
  • Prostatitis — inflammation or infection of the prostate.
  • Ejaculation — raises PSA briefly.
  • Cycling and strenuous exercise — some studies show a temporary rise; not all studies agree.
  • Procedures on the urinary tract — prostate biopsy, cystoscopy, a urinary catheter. After a biopsy, PSA can stay raised for a month or two.
  • Age — PSA gradually rises over the years even with a normal prostate.
  • Testosterone and medicines that raise testosterone levels.

There is also the opposite situation — medicines that lower PSA. The main ones are 5-alpha reductase inhibitors (finasteride, dutasteride), which are prescribed for an enlarged prostate. According to the FDA, they reduce PSA by about 50% within roughly 6 months. So in a man taking them, a PSA of 2 ng/mL may correspond to about 4 ng/mL without the drug. And any confirmed rise in PSA on these medicines needs attention, even if the number stays within the “normal” range.

If you take finasteride or dutasteride, always tell the doctor who is reviewing your PSA. Without this correction, the result can look more reassuring than it really is.

How to take the test without getting a false alarm

The NCI advises avoiding things that temporarily raise PSA for 2 days before the test: ejaculation, cycling and strenuous exercise. If you have recently had a prostate biopsy, a cystoscopy or a catheter, or if you have a flare of prostatitis or a urinary tract infection, discuss with your doctor when to take the test: a result taken “in the heat of the moment” may be falsely high.

Another practical point: repeat tests are best done at the same laboratory. The European Association of Urology (EAU) guidelines state directly that comparisons need the same laboratory and the same assay — results from different assays can differ slightly.

What PSA level counts as high

There is no single line between “normal” and “cancer”. Cancer can occur at any PSA level, and a high PSA does not always mean cancer. Reference points according to the American Cancer Society:

PSA level What it usually means
Below 4 ng/mL Most men without cancer have a PSA in this range. But about 15% of men with a PSA below 4 are found to have cancer on biopsy
4–10 ng/mL (“borderline range”) The chance of cancer is about 1 in 4
Above 10 ng/mL The chance of cancer is over 50%

Many doctors use a cut-off of 4 ng/mL, some use 2.5 or 3. Age-adjusted limits are sometimes used: according to the NCI, about 2.5 ng/mL for younger men and about 5 ng/mL for older men. But the value of age-specific ranges is not well proven, and most professional organizations do not currently recommend them. In practice, a doctor looks not only at the number but also at age, prostate size, the trend over time and the examination findings.

I wrote about why no tumor marker should be read in isolation from the rest of the picture in my article on tumor markers.

Your PSA is raised. What next?

If PSA is raised and you have no symptoms, the first step is usually a repeat test. The EAU advises repeating it after about 4 weeks for a PSA of 3–10 ng/mL before ordering anything else. If the level has returned to normal, the next check is in a year.

If the rise is confirmed, a few additional measures help.

Free PSA. In the blood, PSA is either bound to proteins or free. With cancer, the proportion of free PSA is usually lower. According to the American Cancer Society, with a total PSA of 4–10 ng/mL and free PSA of 10% or less, many doctors recommend a biopsy; at 10–25%, they consider one. There is no single cut-off, and the interpretation depends on the total PSA level.

PSA density. This is PSA divided by prostate volume (measured by ultrasound or MRI). The logic is simple: a large prostate with hyperplasia produces more PSA, so a high number means less in that case. The higher the density, the more likely a clinically significant cancer. The MSD Manual suggests considering a biopsy at a density of 0.15 or above (sometimes from 0.10). According to the EAU, at a density below 0.09 the chance of clinically significant cancer was about 4%.

Prostate MRI before biopsy. This is the main change of recent years. The EAU, with a strong recommendation, advises using MRI in men without symptoms with a PSA of 3–20 ng/mL to decide whether a biopsy is needed. MRI findings are scored on the PI-RADS scale: PI-RADS 3–5 lesions are considered suspicious, and the biopsy is targeted at those areas. If the MRI is reassuring (PI-RADS 1–2) and PSA density is low, a biopsy can sometimes be avoided and monitoring continued. You can read more about how MRI differs from CT and PET-CT in my article on imaging methods.

If cancer is found: active surveillance is also an option

Not every prostate cancer that is found needs immediate surgery or radiotherapy. For low-risk cancer (and sometimes intermediate-risk) without symptoms, active surveillance is possible: regular PSA tests, examinations, repeat MRI scans and biopsies on a schedule. Treatment starts if the tumor begins to grow or becomes more aggressive. According to the MSD Manual, about 30% of men on active surveillance eventually move on to treatment.

The point is to spare a man the side effects of surgery or radiotherapy (urinary incontinence, erectile problems) while the tumor is behaving quietly. This is not “doing nothing” — it is treatment with a deferred start under close monitoring. The decision is made together with a urologist, and sometimes a radiation oncologist.

PSA after treatment: what biochemical recurrence means

After radical treatment, PSA becomes the main monitoring tool. A rise often appears months or years before any symptoms. This is called biochemical recurrence — the tumor is not yet visible on scans, but it is “visible” in the blood test.

Situation What we expect When we become concerned
After removal of the prostate Ideally, PSA is undetectable PSA above 0.2 ng/mL; some doctors use a cut-off of 0.1 ng/mL
After radiotherapy PSA falls to its lowest level (the nadir), but not necessarily to zero — the remaining prostate tissue still produces it A rise of 2 ng/mL above the nadir on two consecutive tests

After radiotherapy, a PSA “bounce” can happen — a temporary rise that then settles on its own. It usually occurs 12 months to 2 years after treatment ends. So a single raised value after radiotherapy is a reason to repeat the test, not to change the plan straight away.

Besides the level, the rate of rise matters — the PSA doubling time. This is how long it takes for the value to double. According to the Prostate Cancer Foundation, a doubling time under 6 months is linked to more aggressive disease, and a longer one to a calmer course. This determines whether treatment is needed now and what kind.

If PSA is rising, PSMA PET-CT is increasingly used to look for disease — a scan that can find small deposits while PSA is still low. I covered how follow-up after treatment works in general in my article on cancer recurrence.

When to contact a doctor urgently

A raised PSA on its own is not an emergency. Call your urologist urgently if after a prostate biopsy you develop a fever, chills, difficulty passing urine or a lot of blood in your urine. Call your local emergency number (911 in the US, 999 in the UK, 112 in the EU) if you cannot pass urine at all, have a high fever with chills and weakness, or severe pain.

Questions to ask your doctor

  • Should I repeat the PSA test before any decisions are made, and when?
  • Have my medicines (finasteride, dutasteride, testosterone) been taken into account?
  • What is my PSA density, and do I need a free PSA test?
  • Can I have a prostate MRI first, and a biopsy only if suspicious areas are found?
  • If cancer is found, am I a candidate for active surveillance?
  • After treatment: what PSA level should worry me, and how often should I have it checked?

If your PSA is raised, or you already have MRI and biopsy results and want to understand what they mean, I’ll review your documents at a consultation — after our conversation, I’ll send you a written summary.

Sources

  1. Screening Tests for Prostate Cancer — American Cancer Society, accessed 2026
  2. Prostate-Specific Antigen (PSA) Test — National Cancer Institute, accessed 2026
  3. Prostate Cancer Guidelines: Diagnostic Evaluation — European Association of Urology, accessed 2026
  4. FDA Drug Safety Communication: 5-alpha reductase inhibitors (5-ARIs) may increase the risk of a more serious form of prostate cancer — U.S. FDA, 2011
  5. PSA Monitoring and Detecting Recurrence — Prostate Cancer Foundation, accessed 2026
  6. Prostate Cancer — MSD Manual Professional Version, accessed 2026

Frequently asked questions

This article is for information only and does not replace a consultation with your treating doctor. Decisions about tests and treatment are made by the doctor who looks after you.